PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sotio

SOTIO Entered into a License Agreement with Synaffix to Expand ADC Pipeline

SOTIO Entered into a License Agreement with Synaffix to Expand ADC Pipeline

October 17, 2023

PharmaShots Weekly Snapshots (January 16 - 20, 2023)

PharmaShots Weekly Snapshots (January 16 - 20, 2023)

January 20, 2023

SOTIO Reports First Patient Dosing of Nanrilkefusp Alfa in P-II Trial (AURELIO-05) for Colorectal Cancer

SOTIO Reports First Patient Dosing of Nanrilkefusp Alfa in P-II Trial (AURELIO-05) for Colorectal Cancer

January 20, 2023

PharmaShots Interview: In Conversation with SOTIO’s CMO, Richard Sachse, Where he Shares Insights on New Interim Data presented in an Oral Presentation at AACR 2022 Annual Meeting

PharmaShots Interview: In Conversation with SOTIO’s CMO, Richard Sachse, Where he Shares Insights on New Interim Data presented in...

June 22, 2022

PharmaShots Interview: SOTIO’ Richard Sachse Shares Insight on SOT101 for the Treatment of Advanced/Metastatic Solid Tumors

PharmaShots Interview: SOTIO’ Richard Sachse Shares Insight on SOT101 for the Treatment of Advanced/Metastatic Solid Tumors

April 6, 2022

PharmaShots Weekly Snapshots (November 15 - 19, 2021)

PharmaShots Weekly Snapshots (November 15 - 19, 2021)

November 19, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us